cerca CERCA
Sabato 09 Dicembre 2023
Aggiornato: 00:42
Temi caldi


comunicato stampa

Maltese Patient Received World's First ND1-LHON Gene Therapy Injection Donated by Neurophth in China

WUHAN, China and SAN DIEGO, March 7, 2023 /PRNewswire/ -- Matthias Szabo Zarb, a Maltese college student, was diagnosed with Leber hereditary optic neuropathy caused by ND1 mutation (ND1-LHON) two years ago, which led to a rapid deterioration in his visual acuity and inability to engage in normal activities. Through the National Alliance for Rare Diseases Support, he learned about NFS-02, a gene therapy drug targeting ND1-LHON which is developed by the Chinese ophthalmic gene therapy company, Neu...

comunicato stampa

Servier receives a positive CHMP opinion for Tibsovo® in IDH1-mutated Acute Myeloid Leukemia (AML) and Cholangiocarcinoma (CCA) patients

PARIS, Feb. 24, 2023 /PRNewswire/ -- Servier, a global pharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing authorization for Tibsovo® (ivosidenib tablets) - an inhibitor of the mutated isocitrate dehydrogenase-1 (IDH1) enzyme - for two indications:

comunicato stampa

Gerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels

DUESSELDORF, Germany, Feb. 23, 2023 /PRNewswire/ -- Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reports double digit growth in revenues and adjusted EBITDA for FY 2022. Revenue rose organically by 16.2%, driven by all divisions. Adjusted EBITDA grew organically by 10.2%. "In 2022, Gerresheimer has proven that it is a profitable growth company, accelerating growth across all businesses. We have exceeded our targe...


Molteni Farmaceutici e gli imprenditori delle FAB13 incontrano Adolfo Urso

Milano, 17 Febbraio 2023. Molteni Farmaceutici, azienda di riferimento a livello europeo nello sviluppo e produzione di farmaci analgesici-oppioidi per la terapia del dolore e il trattamento delle tossicodipendenze, insieme agli imprenditori delle FAB13, le tredici aziende italiane medio-grandi del farmaco aderenti a Farmindustria, ha partecipato all’incontro con il Ministro delle Imprese e del Made in Italy, Adolfo Urso.

comunicato stampa

China's First Integrated Methanol-to-Hydrogen and Hydrogen Refueling Service Station Now in Operation

DALIAN, China, Feb. 16, 2023 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") officially launched China's first methanol-to-hydrogen and hydrogen refueling service station (the "Service Station") in Dalian, China yesterday. An upgrade from the previous fueling station offering oil, gas, hydrogen, electric charging services, the integrated complex can produce 1,000 kilograms of hydrogen a day, with a purity of 99.999 percent.


whatsapp linkedin twitter youtube facebook instagram
ora in
Prima pagina
Tag più usati
in questa pagina

altro chimica_e_farmacia salute_e_benessere chimica_e_farmacia ict economia_e_finanza


chadds ford

chimica_e_farmacia ambiente

chimica_e_farmacia ict salute_e_benessere economia_e_finanza economia_e_finanza

clarimed opens new office


cphi india

drug discovery software

first end to end medtech

in Evidenza